Applications of coxsackievirus A21 in oncology
Oncolytic Virotherapy · 2014-04 · 47
DOI: 10.2147/ov.s56322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncolytic Virotherapy, 2014-04. Verfasst von Stephen Bradley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Cancer and Pathology, Cancer Research UK and Experimental Cancer Medicine Centre, St James' University Hospital, Leeds, UK. Die Arbeit wurde bisher 98-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leeds Institute of Cancer and Pathology, Cancer Research UK and Experimental Cancer Medicine Centre, St James' University Hospital, Leeds, UK.
- Division of Cancer Biology, The Institute of Cancer Research, London, UK.
- Oncology Department, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Zitieren
APA
Bradley, S., Jakes, A. D., Harrington, K., Pandha, H., Melcher, A., & Errington-Mais, F. (2014). Applications of coxsackievirus A21 in oncology. Oncolytic Virotherapy, 47. https://doi.org/10.2147/ov.s56322
Vancouver
Bradley S, Jakes AD, Harrington K, Pandha H, Melcher A, Errington-Mais F. Applications of coxsackievirus A21 in oncology. Oncolytic Virotherapy. 2014:47. doi:10.2147/ov.s56322
BibTeX
@article{Bradley2014,
author = {Bradley, Stephen and Jakes, Adam D and Harrington, Kevin and Pandha, Hardev and Melcher, Alan and Errington-Mais, Fiona},
title = {Applications of coxsackievirus A21 in oncology},
journal = {Oncolytic Virotherapy},
year = {2014},
pages = {47},
doi = {10.2147/ov.s56322}
}
EUVIMED